Short Interest in Cosmos Health Inc. (NASDAQ:COSM) Decreases By 19.5%

Cosmos Health Inc. (NASDAQ:COSM) was the recipient of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 646,900 shares, a decrease of 19.5% from the February 28th total of 804,000 shares. Approximately 4.0% of the shares of the stock are short sold. Based on an average trading volume of 414,400 shares, the days-to-cover ratio is currently 1.6 days.

Insiders Place Their Bets

In other news, CEO Grigorios Siokas acquired 29,158 shares of Cosmos Health stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $0.86 per share, with a total value of $25,075.88. Following the acquisition, the chief executive officer now owns 4,164,789 shares in the company, valued at $3,581,718.54. This represents a 0.71 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have purchased a total of 832,506 shares of company stock valued at $502,164 in the last 90 days. 15.61% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC boosted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 29.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 193,432 shares of the company’s stock after acquiring an additional 43,704 shares during the period. Geode Capital Management LLC owned 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the SEC. 12.61% of the stock is owned by hedge funds and other institutional investors.

Cosmos Health Trading Down 3.3 %

Shares of COSM opened at $0.44 on Tuesday. The stock’s fifty day simple moving average is $0.60 and its 200-day simple moving average is $0.70. The company has a quick ratio of 1.24, a current ratio of 1.44 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $10.14 million, a PE ratio of -0.18 and a beta of 5.60. Cosmos Health has a 12-month low of $0.35 and a 12-month high of $1.58.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.